03023nam 2200745Ia 450 991096376760332120251117115346.01-280-08588-697866100858800-585-47640-310.1596/0-8213-5578-3(CKB)111087027997072(SSID)ssj0000087356(PQKBManifestationID)11113436(PQKBTitleCode)TC0000087356(PQKBWorkID)10054122(PQKB)10880784(MiAaPQ)EBC3050604(Au-PeEL)EBL3050604(CaPaEBR)ebr10044400(CaONFJC)MIL8588(OCoLC)53225551(The World Bank)ocm53158284(US-djbf)13430770(BIP)46128465(BIP)9703746(EXLCZ)9911108702799707220031007d2003 uf 0engurcn|||||||||txtrdacontentcrdamediacrrdacarrierHIV/AIDS in the Middle East and North Africa the costs of inaction /Carol Jenkins, David A. Robalino1st ed.Washington, D.C. World Bank2003xxii, 173 pages illustrations ;26 cmOrientations in developmentBibliographic Level Mode of Issuance: Monograph0-8213-5578-3 Includes bibliographical references and index.Intro -- Contents -- Preface -- Acronyms and Abbreviations -- Executive Summary -- Introduction -- 1. Global Experience with HIV/AIDS -- 2. Review of the HIV/AIDS Situation in the MENA/EM Region -- 3. A Typology of Risk Factors -- 4. Assessing the Potential Economic Impact of HIV/AIDS in the MENA/EM Region -- 5. Responses to HIV/AIDS -- 6. A Way Forward -- Technical Appendix -- References -- Index -- Boxes -- Figures -- Tables.This work shows that although most evidence suggests HIV prevalence is low in the Middle East and North Africa region, greater investments in improved surveillance, prevention, and care are needed - to maintain low prevalence levels and preserve the focus on national and regional development goals.Orientations in development.HIV infectionsAfrica, NorthHIV infectionsMiddle EastAIDS (Disease)Africa, NorthAIDS (Disease)Middle EastHIV infectionsHIV infectionsAIDS (Disease)AIDS (Disease)362.196/9792Jenkins Carol Lynn1866735Robalino David A858960World Bank.World Health Organization.Regional Office for the Eastern Mediterranean.Joint United Nations Programme on HIV/AIDS.MiAaPQMiAaPQMiAaPQBOOK9910963767603321HIV4474163UNINA